ストックスクリーナーアプリを入手
75.24
2.38%
1.75
アフターアワーズ：
75.24
前日終値:
$73.49
開ける：
$74.05
24時間の取引高:
561.56K
Relative Volume:
1.01
時価総額：
$3.78B
収益：
$1.36B
当期純損益:
$123.81M
株価収益率:
31.22
EPS:
2.41
ネットキャッシュフロー:
$20.35M
1週間 パフォーマンス:
-5.90%
1か月 パフォーマンス:
-0.27%
6か月 パフォーマンス:
-15.20%
1年 パフォーマンス:
-10.39%
1日の値動き範囲:
$73.76
$75.88
1週間の範囲:
$69.29
$82.25
52週間の値動き範囲:
$69.29
$97.97
Haemonetics Corp Stock (HAE) Company Profile
HAE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
75.24 | 3.78B | 1.36B | 123.81M | 20.35M | 2.41 |
|
ISRG
Intuitive Surgical Inc
|
604.12 | 215.18B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
240.37 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
88.54 | 43.79B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
247.79 | 36.40B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
344.69 | 25.00B | 2.88B | 499.60M | 321.60M | 6.74 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-06 | 開始されました | JP Morgan | Overweight |
| 2024-11-08 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | 開始されました | CL King | Buy |
| 2024-09-11 | 開始されました | BofA Securities | Neutral |
| 2024-09-10 | 開始されました | BTIG Research | Buy |
| 2024-06-12 | アップグレード | Needham | Hold → Buy |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2022-01-27 | ダウングレード | Needham | Buy → Hold |
| 2021-12-15 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-08-17 | 再開されました | Raymond James | Outperform |
| 2021-06-17 | 開始されました | Citigroup | Buy |
| 2021-05-14 | アップグレード | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | ダウングレード | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | アップグレード | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | 開始されました | Needham | Buy |
| 2019-08-07 | 繰り返されました | Barrington Research | Outperform |
| 2019-05-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | 繰り返されました | Barrington Research | Outperform |
| 2018-08-09 | 繰り返されました | Barrington Research | Outperform |
| 2018-02-07 | 繰り返されました | Barrington Research | Outperform |
| 2018-01-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | 繰り返されました | Barrington Research | Outperform |
| 2017-08-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | 繰り返されました | The Benchmark Company | Hold |
| 2016-09-20 | ダウングレード | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | ダウングレード | Sidoti | Buy → Neutral |
| 2016-08-02 | 繰り返されました | Jefferies | Buy |
| 2016-08-02 | 繰り返されました | The Benchmark Company | Hold |
すべてを表示
Haemonetics Corp (HAE) 最新ニュース
Completion of Whole Blood Assets Sale to GVS Likely to Boost HAE Stock - Yahoo Finance
Haemonetics (NYSE:HAE) Reaches New 1-Year LowHere's Why - MarketBeat
Haemonetics stock hits 52-week low at $70.1 amid challenges - MSN
Haemonetics (NYSE:HAE) Shares Down 3.2%Here's What Happened - MarketBeat
Haemonetics Co. (NYSE:HAE) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Haemonetics Completes $67.8 Million Sale of Whole Blood Assets to GVS – Market - HPBL
Haemonetics Sells Whole Blood Assets to GVS for $67.8M, Focuses on Core Apheresis Business - StockTitan
Haemonetics Sets Q3 FY2025 Earnings Call for February 6Financial Results Preview - StockTitan
Why Haemonetics (HAE) is a Top Value Stock for the Long-Term - Yahoo Finance
Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference - Quantisnow
Haemonetics Co. (NYSE:HAE) Short Interest Up 7.4% in December - MarketBeat
Principal Financial Group Inc. Sells 37,433 Shares of Haemonetics Co. (NYSE:HAE) - MarketBeat
Principal Financial Group Inc. Has $12.48 Million Holdings in Haemonetics Co. (NYSE:HAE) - Defense World
HighTower Advisors LLC Sells 556 Shares of Haemonetics Co. (NYSE:HAE) - Defense World
Here's Why You Should Add HAE Stock to Your Portfolio Now - Yahoo Finance
Down -11.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Haemonetics (HAE) - Yahoo Finance
Haemonetics Co. (NYSE:HAE) Shares Purchased by Stifel Financial Corp - Defense World
Analysts Set Haemonetics Co. (NYSE:HAE) PT at $108.78 - MarketBeat
Investors three-year returns in Haemonetics (NYSE:HAE) have not grown faster than the company's underlying earnings growth - Yahoo Finance
Haemonetics Co. (NYSE:HAE) Position Lifted by Geode Capital Management LLC - MarketBeat
Zacks Research Predicts Haemonetics’ Q4 Earnings (NYSE:HAE) - Defense World
Zacks Research Forecasts Haemonetics' Q4 Earnings (NYSE:HAE) - MarketBeat
Zacks Research Forecasts Higher Earnings for Haemonetics - MarketBeat
Platelet Aggregation Devices Market Overall Study Report - openPR
BNP Paribas Financial Markets Has $1.36 Million Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Fmr LLC Has $62.26 Million Stake in Haemonetics Co. (NYSE:HAE) - MarketBeat
The Manufacturers Life Insurance Company Sells 248,835 Shares of Haemonetics Co. (NYSE:HAE) - MarketBeat
JPMorgan sets Haemonetics stock overweight with $116 target By Investing.com - Investing.com Nigeria
Settlement checks in the mail from Vizio, Haemonetics - Top Class Actions
Are Investors Undervaluing Haemonetics (HAE) Right Now? - Yahoo Finance
JPMorgan sets Haemonetics stock overweight with $116 target - Investing.com India
Haemonetics (NYSE:HAE) Now Covered by Analysts at JPMorgan Chase & Co. - MarketBeat
Haemonetics (HAE) Shares Cross Below 200 DMA - Nasdaq
Zacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and Agios - Yahoo Finance
Holocene Advisors LP Takes $5.42 Million Position in Haemonetics Co. (NYSE:HAE) - MarketBeat
The Latest Analyst Ratings For Haemonetics - Inkl
Wall Street Analysts See a 27.84% Upside in Haemonetics (HAE): Can the Stock Really Move This High? - Yahoo Finance
Will HAE Stock Gain Following Sell-Off of Whole Blood Assets to GVS? - Yahoo Finance
7,746 Shares in Haemonetics Co. (NYSE:HAE) Purchased by Paloma Partners Management Co - MarketBeat
Haemonetics to offload whole-blood business for up to $67M - Yahoo Finance
Haemonetics stock still a Buy as Whole Blood sale aligns with margin improvement efforts - Investing.com
Atom Investors LP Takes $1.57 Million Position in Haemonetics Co. (NYSE:HAE) - MarketBeat
Bridgewater Associates LP Has $629,000 Stock Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A - PR Newswire
Q3 EPS Estimates for Haemonetics Lowered by Zacks Research - MarketBeat
Zacks Research Decreases Earnings Estimates for Haemonetics - Defense World
Isthmus Partners LLC Decreases Stock Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Citigroup Inc. Sells 5,678,717 Shares of Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics Co. (NYSE:HAE) Shares Purchased by Loomis Sayles & Co. L P - MarketBeat
Intech Investment Management LLC Boosts Stake in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics Co. (NYSE:HAE) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Haemonetics Corp (HAE) 財務データ
収益
当期純利益
現金流量
EPS
1.54%
0.92%
大文字化:
|
ボリューム (24 時間):